SCHEMBL7252845

SCHEMBL7252845

CC(C)CCc1[c]cccc1CNC1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.40
HTT P42858 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 3/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PKM P14618 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
ALOX15 P16050 1/20 0.36
SLC2A1 P11166 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7244710 0.99 PABPC1 (0.38) PABPC1HTTKMT2ALMNAKDM4E
SCHEMBL7243657 0.96 PABPC1 (0.35) PABPC1HTTKMT2ALMNAKDM4E
SCHEMBL7251006 0.93 KMT2A (0.33) PABPC1HTTKMT2ALMNAKDM4E
SCHEMBL7250851 0.79 BCHE (0.37) KMT2AALDH1A1
SCHEMBL7252126 0.77 MEN1 (0.46) HTTKMT2AMEN1CYP2D6
SCHEMBL5110869 0.77 SLC6A4 (0.32)
SCHEMBL7252847 0.76 PABPC1 (0.40) PABPC1HTTKMT2ALMNAKDM4E
SCHEMBL8856420 0.76 HRH3 (0.62) HTTKMT2AKDM4EMEN1PKM
SCHEMBL7244714 0.75 PABPC1 (0.38) PABPC1HTTKMT2ALMNAKDM4E
SCHEMBL677325 0.75 SLC6A2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627624-B1 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, NEUROGEN CORPORATION 2003-09-30 US disclosed